Drug Formulary

Welcome to the NHS Shropshire CCG Formulary Page

A new online formulary is currently being compiled by the Area Prescribing Committee with professional input from:  

NHS Shropshire CCG
NHS Telford & Wrekin CCG
Shrewsbury and Telford Hospitals NHS Trust
Robert Jones & Agnes Hunt Orthopaedic Hospital NHS Foundation Trust
Midlands Partnership NHS Foundation Trust

This formulary will provide a universal guide to medication/products, which will be used across the whole Local area to provide a single health economy formulary. The formulary is nearly complete, the website can be accessed and a selection of BNF Chapters are available for use.

To access the site and learn to navigate chapters, news and other features click HERE

The online net formulary consists of list of preferred treatment choices, selected from the wide range of medicines available. It is intended to be used when a clinician reviews or initiates a treatment.

The formulary is listed in BNF order. If a drug is not included then it is considered non-formulary. Non-formulary choices may be prescribed under certain circumstances please contact Medicines Management Team for further advice about prescribing non-formulary choices.

The formulary is not a comprehensive guide to all the medicines available, reference to the British National Formulary and Summary of Product Characteristics may still be required and these links can be found at the bottom of this page.

Next to each medicine there may be prescribing points relevant to the drug, hyperlinks to locally developed supporting information, NICE and MTRAC materials where available.

To facilitate the implementation of the formulary an electronic formulary ready to integrate into GP systems is available. In addition Shropshire CCG has funded ScriptSwitch® software which directs prescribers to the preferred choices, as well as advising about shared care and specially commissioned drugs.

The preferred list is based on NICE guidance, Technology appraisals, local Area Prescribing Committee formulary decisions and MTRAC opinion. The formulary list is continually reviewed.

The decisions about formulary drug inclusions are considered at the Area Prescribing Committee meetings. The formulary does not include all licensed products within a therapeutic class but includes medicines that offer a wide range of clinical applications, best quality published evidence with an emphasis on patient orientated outcomes and value for money.

We hope that the formulary provides clinicians with flexibility and sufficient choice to cover 80-90% of prescribing.

British National Formulary link here

Summary of Product Characteristics link here